Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction.
Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. have?
Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. has 63 citations in the OpenAlex counts ScholarIQ stores.
When was Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. published?
Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. has 2017 year in the ScholarIQ index.
What is the open-access status of Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction.?
Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. has green oa status in the ScholarIQ index.
What is the PMID of Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction.?
The PMID for Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. is on the source record.
What is the OpenAlex record for Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction.?
The OpenAlex for Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. is on the source record.